These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 19220265)

  • 21. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
    Zehnder P; Studer UE; Skinner EC; Dorin RP; Cai J; Roth B; Miranda G; Birkhäuser F; Stein J; Burkhard FC; Daneshmand S; Thalmann GN; Gill IS; Skinner DG
    J Urol; 2011 Oct; 186(4):1261-8. PubMed ID: 21849183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superiority of ratio based lymph node staging for bladder cancer.
    Herr HW
    J Urol; 2003 Mar; 169(3):943-5. PubMed ID: 12576818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.
    Fritsche HM; May M; Denzinger S; Otto W; Siegert S; Giedl C; Giedl J; Eder F; Agaimy A; Novotny V; Wirth M; Stief C; Brookman-May S; Hofstädter F; Gierth M; Aziz A; Kocot A; Riedmiller H; Bastian PJ; Toma M; Wieland WF; Hartmann A; Burger M
    Eur Urol; 2013 Apr; 63(4):739-44. PubMed ID: 23079053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does extended lymph node dissection affect the lymph node density and survival after radical cystectomy?
    Dharaskar A; Kumar V; Kapoor R; Jain M; Mandhani A
    Indian J Cancer; 2011; 48(2):230-3. PubMed ID: 21768672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of lymphadenectomy in high-grade invasive bladder cancer.
    Stein JP; Skinner DG
    Urol Clin North Am; 2005 May; 32(2):187-97. PubMed ID: 15862616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability of frozen section examination of external iliac, hypogastric, and obturator lymph nodes during radical cystectomy: a multicenter study.
    Adsan O; Baltaci S; Cal C; Büyükalpelli R; Uğurlu O; Bozlu M; Türkölmez K; Sahin H; Elhan A
    Urology; 2007 Jan; 69(1):83-6. PubMed ID: 17270622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robotic and laparoscopic high extended pelvic lymph node dissection during radical cystectomy: technique and outcomes.
    Desai MM; Berger AK; Brandina RR; Zehnder P; Simmons M; Aron M; Skinner EC; Gill IS
    Eur Urol; 2012 Feb; 61(2):350-5. PubMed ID: 22036642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer.
    Shirotake S; Kikuchi E; Matsumoto K; Yazawa S; Kosaka T; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2010 Mar; 40(3):247-51. PubMed ID: 19887521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
    Jensen JB; Ulhøi BP; Jensen KM
    Int J Urol; 2012 Jan; 19(1):39-47. PubMed ID: 22050425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
    Gschwend JE; Heck MM; Lehmann J; Rübben H; Albers P; Wolff JM; Frohneberg D; de Geeter P; Heidenreich A; Kälble T; Stöckle M; Schnöller T; Stenzl A; Müller M; Truss M; Roth S; Liehr UB; Leißner J; Bregenzer T; Retz M
    Eur Urol; 2019 Apr; 75(4):604-611. PubMed ID: 30337060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lymph node yield during robot-assisted radical cystectomy.
    Guru KA; Sternberg K; Wilding GE; Tan W; Butt ZM; Mohler JL; Kim HL
    BJU Int; 2008 Jul; 102(2):231-4; discussion 234. PubMed ID: 18325058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reassessing the current TNM lymph node staging for renal cell carcinoma.
    Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR
    Eur Urol; 2006 Feb; 49(2):324-31. PubMed ID: 16386352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
    Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic radical cystectomy for cancer: oncological outcomes at up to 5 years.
    Haber GP; Gill IS
    BJU Int; 2007 Jul; 100(1):137-42. PubMed ID: 17552961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Dhar NB; Jones JS; Reuther AM; Dreicer R; Campbell SC; Sanii K; Klein EA
    BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presacral and retroperitoneal lymph node involvement in urothelial bladder cancer: results of a prospective mapping study.
    Miocinovic R; Gong MC; Ghoneim IA; Fergany AF; Hansel DE; Stephenson AJ
    J Urol; 2011 Oct; 186(4):1269-73. PubMed ID: 21849181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.